Back to West Virginia

HB5556 • 2026

Creating an external reference pricing pilot program for prescription drugs.

Creating an external reference pricing pilot program for prescription drugs.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Holstein, Cannon, J. , Linville , Rohrbach , Funkhouser
Last action
2026-02-16
Official status
H To House Health and Human Resources 02/16/26
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2026-02-16 H

    To House Health and Human Resources

  2. 2026-02-16 H

    Introduced in House

  3. 2026-02-16 H

    To Health and Human Resources

  4. 2026-02-16 H

    Filed for introduction

Official Summary Text

Creating an external reference pricing pilot program for prescription drugs.

Current Bill Text

Read the full stored bill text
HB 5556 Text

skip navigation

SENATE

PRESIDENT

SENATORS

COMMITTEES

VIDEO/AUDIO

DISTRICT MAPS

SENATE CLERK

SENATE RULES

HOUSE

SPEAKER

DELEGATES

COMMITTEES

VIDEO/AUDIO

DISTRICT MAPS

HOUSE CLERK

HOUSE RULES

HOUSE STAFF

JOINT

INTERIM COMMITTEES

LEGISLATIVE ADMINISTRATOR

LEGISLATIVE SERVICES DIVISION

PUBLIC INFORMATION

LEGISLATIVE AUTOMATED SYSTEMS DIVISION

LEGISLATIVE AUDITOR'S OFFICE

PERFORMANCE EVALUATION & RESEARCH DIVISION

POST AUDIT DIVISION

BUDGET DIVISION

REGULATORY AND FISCAL AFFAIRS DIVISION

CLAIMS COMMISSION

CRIME VICTIMS

RULE-MAKING REVIEW

SPECIAL INVESTIGATIONS

JUDICIAL COMP. COMMISSION

JOINT RULES

STAFF INFO

BILL STATUS

BILL STATUS

BILL TRACKING

STATE LAW

WEST VIRGINIA CODE

ACTS OF THE LEGISLATURE

CODE OF 1931

WV CONSTITUTION

US CONSTITUTION

REPORTS

AGENCY REPORTS

AGENCY GRANT AWARDS

PERFORMANCE EVALUATIONS

POST AUDITS

EDUCATIONAL

CITIZEN’S GUIDE

INTERNSHIP PROGRAM

PAGE PROGRAM

PUBLICATIONS

PHOTO GALLERY

CAPITOL HISTORY

HOW A BILL BECOMES LAW

CONTACT

SENATE ROSTER

HOUSE ROSTER

PUBLIC INFO.

NEWS RELEASES

HELPFUL LINKS

Introduced Version

House Bill 5556 History

|
Email

Key:
Green
= existing Code.
Red
= new code to be enacted

WEST VIRGINIA LEGISLATURE
2026
REGULAR SESSION
Introduced
House Bill 5556
By Delegates Holstein, J. Cannon, Linville, Rohrbach, and Funkhouser
[Introduced February 16, 2026; referred to the Committee on Health and Human Resources]
A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §9-5-29b, relating to the Department of Human Services establishing an external reference pricing pilot program for prescription drugs.
Be it enacted by the Legislature of West Virginia:

ARTICLE 5. MISCELLANEOUS PROVISIONS
.

§9-5-29b. External reference pricing pilot program
.

(a) The Department of Human Services may establish a pilot program applying external reference pricing for selected high-cost prescription drugs purchased or reimbursed under the state Medicaid program.

(b) For purposes of this section, “external reference pricing” means setting a maximum reimbursement rate for a prescription drug based on the lowest price paid for the same or therapeutically equivalent drug in one or more comparable industrialized nations, or as established through a federally recognized most-favored-nation pricing methodology.
(c) The pilot program shall:
(1) Apply only to a limited number of prescription drugs identified by the department as having significant cost impact on the Medicaid program;
(2) Exclude drugs for which no appropriate international price comparison exists;
(3) Preserve beneficiary access to medically necessary medications.
(d) The department may:
(1) Negotiate supplemental rebates with manufacturers;
(2) Establish exceptions or alternative reimbursement rates when necessary to prevent drug shortages or access disruptions; and
(3) Coordinate pricing methodologies with federal prescription drug pricing initiatives when available.
(e) The pilot program shall be implemented for a period not to exceed three years, unless extended by the Legislature.
(f) No later than December 1 of each year during the pilot period, the department shall submit a report to the Joint Committee on Government and Finance evaluating:
(1) Cost savings achieved;
(2) Effects on drug availability and beneficiary access;
(3) Manufacturer participation; and
(4) Recommendations for continuation, modification, or termination of the program.
(g) Nothing in this section may be construed to require participation by private insurers or to alter existing pharmaceutical benefit contracts outside the Medicaid program.

NOTE: The purpose of this bill is to authorize the Department of Human Services to establishing an external reference pricing pilot program for prescription drugs.
Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added.

Bill Status
|

Bill Tracking
|

Legacy WV Code
|

Bulletin Board
|

District Maps
|

Senate Roster
|

House Roster
|

Live
|

Blog
|

Jobs
|

Links
|

Home

This Web site is maintained by the
West Virginia Legislature's Office of Reference & Information.
|
Terms of Use
|

Webmaster
| © 2026 West Virginia Legislature **

Print On Demand

Name:

Email:

Phone: